AAA - Abdominal Aortic Aneurysm
Conditions
Keywords
AAA, aneurysm shrinkage, EVAR, aneurysm remodeling, artificial intelligence, AI
Brief summary
The goal of this observational study is to find out what factors contribute to a good treatment outcome in patients who have received a stent for their dilation of the main abdominal artery (abdominal aortic aneurysm or AAA). The primary goal of this study is to build a prediction model for abdominal aortic aneurysm shrinkage one year after the treatment.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Age ≥ 18 years; * Elective, initially technically successful (as described by the ESVS guidelines11), infrarenal EVAR for unruptured infrarenal AAA; * Implanted endograft is a Gore Excluder, Medtronic Endurant, Cook Zenith, Cordis Incraft, Endologix AFX, Jotec E-Tegra, or Vascutek Anaconda endograft; * Follow-up of the AAA of at least one year with imaging of the same modality as the preoperative imaging; * Axial reconstructions of preoperative CT angiography available, preferably in the arterial phase and with 3 mm or smaller slice thickness.
Exclusion criteria
* Patients with ruptured or symptomatic AAA; * Patients that were treated with fenestrated or branched endografts, iliac branched devices, non-CE marked devices within trial setting, other endografts (EVAS cases) or chimney procedures; * Acute procedures; * Reintervention before one year follow-up; * Revision cases after previous open or endovascular aneurysm repair of an AAA;
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prediction model for AAA shrinkage | Preoperative, peroperative and postoperative (until 1-year visit) data | A prediction model to predict AAA shrinkage one-year after EVAR, it can consist of multiple CTA-scans and/or clinical data. |
Countries
Netherlands, Sweden